Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Long-term Telbivudine in Chronic Hepatitis B (EFFORT Further Extension)
NCT02826070Phase 4Unknown
- Sponsor
- Nanfang Hospital, Southern Medical University
- Start
- Apr 2015
- Primary completion
- Oct 2016
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
A Phase 4 trial of telbivudine in Chronic Hepatitis B (CHB), sponsored by Nanfang Hospital, Southern Medical University. Status: unknown.
02
Drugs
telbivudine
03
Conditions
Chronic Hepatitis B (CHB)
Beyond the preview
Go deeper on NCT02826070.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02826070.